SurvivorNet on MSN
'Practice-changing': FDA approves Ibrance combination as new maintenance option for HR+/HER2+ metastatic breast cancer
The FDA has approved palbociclib (Ibrance) in combination with trastuzumab (Herceptin), endocrine therapy, and optionally ...
The EMA’s human medicines committee has recommended approval of a fixed-dose combination of Roche’s breast cancer drugs Herceptin and Perjeta – part of the company’s defense against Herceptin ...
Roche has secured EU approval for Phesgo, a fixed-dose combination of its breast cancer drugs Herceptin and Perjeta that is easier and cheaper to administer to patients – and also provides a defence ...
Hi. I'm Tim and this is my pronunciation workshop. Here, I'm going to show you how English is really spoken. Come on, let's go inside. You see this? This is my lunch - well, either that, or it's some ...
This is the fifth of eight voiceless consonant programmes in our series of videos that explore the sounds of English. This is the fifth of seven short vowel programmes in our series of videos that ...
Rituals seem to be declining in modern life. Finding ways to gather together meaningfully can help us combat loneliness, pain, and division. Decades of research suggest that the quality of our social ...
Introduction Anthracycline chemotherapy, Herceptin and Pertuzumab are commonly used in the management of metastatic breast cancer. All three drugs are known to be cardiotoxic. The aim of this audit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results